Ulys, L.L.C. - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 88 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
Ulys, L.L.C. ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$25,366,000
+71.6%
4,321,2140.0%100.00%0.0%
Q4 2020$14,779,000
+137.5%
4,321,2140.0%100.00%0.0%
Q3 2020$6,222,000
-27.8%
4,321,2140.0%100.00%0.0%
Q2 2020$8,621,000
+2.3%
4,321,2140.0%100.00%0.0%
Q1 2020$8,426,000
-53.0%
4,321,2140.0%100.00%0.0%
Q4 2019$17,933,000
+37.9%
4,321,2140.0%100.00%0.0%
Q3 2019$13,007,000
-52.1%
4,321,2140.0%100.00%0.0%
Q2 2019$27,180,000
+13.1%
4,321,2140.0%100.00%0.0%
Q1 2019$24,026,000
-16.3%
4,321,2140.0%100.00%0.0%
Q4 2018$28,693,000
-37.8%
4,321,2140.0%100.00%0.0%
Q3 2018$46,107,000
-11.1%
4,321,2140.0%100.00%0.0%
Q2 2018$51,855,000
+40.0%
4,321,2140.0%100.00%0.0%
Q1 2018$37,033,000
-13.3%
4,321,2140.0%100.00%0.0%
Q4 2017$42,694,000
-19.6%
4,321,2140.0%100.00%0.0%
Q3 2017$53,108,000
-25.3%
4,321,2140.0%100.00%0.0%
Q2 2017$71,084,000
+14.7%
4,321,2140.0%100.00%0.0%
Q1 2017$61,966,000
+3.7%
4,321,2140.0%100.00%0.0%
Q4 2016$59,762,000
-23.5%
4,321,2140.0%100.00%0.0%
Q3 2016$78,084,000
+25.9%
4,321,2140.0%100.00%
+0.0%
Q2 2016$62,009,000
+20.1%
4,321,2140.0%100.00%
-0.0%
Q1 2016$51,639,000
-10.2%
4,321,2140.0%100.00%0.0%
Q4 2015$57,515,000
+23.9%
4,321,2140.0%100.00%
+0.0%
Q3 2015$46,410,000
+33.4%
4,321,2140.0%99.99%
+0.0%
Q2 2015$34,786,0004,321,21499.98%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$62,009,000100.00%
Artal Group S.A. 57,517,977$825,383,00017.04%
NEA Management Company, LLC 2,382,286$34,186,0001.77%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$512,0001.49%
BRIDGER MANAGEMENT, LLC 1,029,926$14,779,0000.95%
FALCON POINT CAPITAL, LLC 287,809$4,130,0000.71%
HANCOCK WHITNEY CORP 664,025$9,529,0000.40%
KINGDON CAPITAL MANAGEMENT, L.L.C. 494,380$7,094,0000.39%
ELLINGTON MANAGEMENT GROUP LLC 11,700$168,0000.23%
Convergence Investment Partners, LLC 114,157$1,638,0000.22%
View complete list of LEXICON PHARMACEUTICALS INC shareholders